Apoptosis and Senescence in Localized Prostate Cancer Tissues Treated With HDR-BT Boost With Radiotherapy (EBRT) and ADT

被引：0
|
作者：
Chebra, I. [1 ]
机构：
[1] CHU Quebec, Quebec City, PQ, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2518
引用
收藏
页码：E258 / E258
页数：1
相关论文
共 50 条
  • [21] Clinical outcomes and prognostic factors in patients with localized prostate cancer treated HDR BT
    Delishaj, D.
    Soatti, C. P.
    Frigerio, C.
    D'amico, R.
    Bonsignore, F.
    Fumagalli, I. C.
    De Nobili, G.
    Cocchi, A.
    Vola, A.
    Sangalli, G.
    Declich, F.
    Colombo, A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S634 - S635
  • [22] The impact of prostate volume on clinical outcomes in patients with localized prostate cancer treated with HDR boost
    Vigneault, E.
    Despres, P.
    Lavallee, M. C.
    Martin, A. G.
    Foster, W.
    Aubin, S.
    Beaulieu, L.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S74 - S74
  • [23] A method to estimate composite doses for organs at risk in prostate cancer patients treated with EBRT in combination with HDR BT
    Pettersson, Niclas
    Johansson, Karl-Axel
    Alsadius, David
    Tucker, Susan L.
    Steineck, Gunnar
    Olsson, Caroline
    ACTA ONCOLOGICA, 2014, 53 (06) : 815 - 821
  • [24] Single-fraction HDR brachytherapy boost in combination to EBRT for prostate cancer
    Huertas, A.
    Blanchard, P.
    Calmels, L.
    Edouard, M.
    Bossi, A.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S710 - S710
  • [25] RELATIONSHIP BETWEEN TREATMENT PLAN PARAMETERS AND PARTICULAR PROGNOSTIC FACTORS IN PROSTATE CANCER TREATED WITH HIGH-DOSE-RATE BRACHYTHERAPY (HDR-BT) AS A BOOST.
    Chichel, A.
    Kanikowski, M.
    Skowronek, J.
    Dymnicka, M.
    Piotrowski, T.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S339 - S339
  • [26] Clinical outcomes and toxicities of cervical cancer patients treated with HDR-BT after CCRT
    Dayyani, M.
    Rafat-Motavalli, L.
    Hoseinian-Azghadi, E.
    Miri-Hakimabad, H.
    Varshoee-Tabrizi, F.
    Homaee-Shandiz, F.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1943 - S1943
  • [27] Initial experience in inoperable endometrial cancer treated with EBRT plus HDR-BT.
    Ropero Carmona, M. F.
    Quiros Rivero, J.
    Gonzalez Ruiz, M. A.
    Cruz Munoz, C.
    Simon Silva, P.
    Munoz Garcia, J. L.
    Cabrera Rodriguez, J. J.
    Rios Kavadoy, Y.
    Corbacho Campos, A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S820 - S821
  • [28] Nationwide multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for localized prostate cancer: An Asian Prostate HDR-BT Consortium
    Ishiyama, Hiromichi
    Kamitani, Nobuhiko
    Kawamura, Hidemasa
    Kato, Shingo
    Aoki, Manabu
    Kariya, Shinji
    Matsumura, Taisei
    Kaidu, Motoki
    Yoshida, Ken
    Hashimoto, Yaichiro
    Noda, Yasutaka
    Lim, Keith H. C.
    Kawase, Takatsugu
    Takahashi, Takeo
    Inaba, Koji
    Kumano, Motoyasu
    Yoshikawa, Nobuhiko
    Yoshioka, Yasuo
    Nakamura, Katsumasa
    Hiratsuka, Junichi
    Itami, Jun
    Hayakawa, Kazushige
    BRACHYTHERAPY, 2017, 16 (03) : 503 - 510
  • [29] Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer
    Rades, Dirk
    Schwarz, Rudolf
    Todorovic, Manuel
    Thurmann, Horst
    Graefen, Markus
    Walz, Jochen
    Schild, Steven E.
    Dunst, Juergen
    Alberti, Winfried
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 (07) : 398 - 402
  • [30] Excellent local control after intensification with HDR-BT boost in locally advanced breast cancer.
    Martinez, Irene
    Visus, Ignacio
    Fuentemilla, Naiara
    Santiago, Pellejero
    Jablonska, Paola
    Flamarique, Sonia
    Villanueva, Raquel
    Burillo, Erkuden
    Sola, Amaya
    Manterola, Ana
    Ruiz, Ujue
    Isabel Martinez, Maria
    Lorenzana, Patricia
    De La Llana, Victor
    Amondarain, Libe
    Pozo, Darwin
    Barrado, Marta
    Navarrete, Paola
    Almeida, Pilar
    Villafranca, Ines
    Villafranca, Elena
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S161 - S164
12345